Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AFT PHARMACEUTICALS LIMITED Director's Dealing 2017

Jun 18, 2017

64327_rns_2017-06-18_20048211-4468-426d-9ab4-c036891e8f0f.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [109 x 26] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and AFT Pharmaceuticals Limited(AFT)
19-Jun-17
22-Dec-15
Jon Lamb
AFT Pharmaceuticals Limited(AFT)
Not applicable
Director

Fully-Paid OrdinaryShares in AFT
Power to control the exercise of the right to vote
as trustee of the Rivers One Trust which holds
the sharesin Rivers OneLimited
201,305
207,972
Rivers OneLimited
Rivers OneLimited
1
16-Jun-17
Allotment of new Ordinary Shares pursuant to
Share Purchase Plan
Not applicable
NZ$2.25per share
6,667
No
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
AFT Pharmaceuticals Limited(AFT)
19-Jun-17
22-Dec-15
Jon Lamb
AFT Pharmaceuticals Limited(AFT)
Not applicable
Director

Fully-Paid OrdinaryShares in AFT
Power to control the exercise of the right to vote
as trustee of the Rivers One Trust which holds
the sharesin Rivers OneLimited
201,305
207,972
Rivers OneLimited
Rivers OneLimited
1
16-Jun-17
Allotment of new Ordinary Shares pursuant to
Share Purchase Plan
Not applicable
NZ$2.25per share
6,667
No
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Not applicable
Name of listedissuer:
Date this disclosuremade:
Date of last disclosure:
Directororsenior managergiving disclosure
Full name(s):
Name of listedissuer:
Name of related body corporate (ifapplicable):
Position heldin listedissuer:
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:
Class ofaffected quotedfinancialproducts: Fully-Paid OrdinaryShares in AFT
Nature of the affected relevant interest(s): Power to control the exercise of the right to vote
as trustee of the Rivers One Trust which holds
the sharesin Rivers OneLimited
For that relevant interest-
Number heldinclass before acquisitionordisposal: 201,305
Number heldinclass afteracquisitionordisposal: 207,972
Currentregisteredholder(s): Rivers OneLimited
Registeredholder(s) once transfers areregistered: Rivers OneLimited
Details of transactions giving rise to acquisition or disposal
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Date of transaction:
Nature of transaction:
Name of anyotherpartyorparties to the transaction(if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value,describe the consideration:
Number of financialproducts to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include thefollowing details—
Whether relevant interests were acquired or disposed of duringa closedperiod: No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Not applicable
Date ofthe prior writtenclearance (ifany): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
Not applicable
The notional value of the derivative (if any) or the notional amount of underlying financial
products (ifany):
Not applicable
Astatement as towhetherthe derivativeis cashsettled orphysically settled: Not applicable
Maturity date ofthe derivative (ifany): Not applicable
Expiry date ofthe derivative (ifany): Not applicable
The price's specified terms (ifany): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financialproducts:
Not applicable
_For that derivative relevant interest,- _
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant
interestinthe derivative:
Not applicable

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made.

Signature of director or officer:

Date of signature:

==> picture [49 x 59] intentionally omitted <==

==> picture [490 x 48] intentionally omitted <==

19-Jun-17